Rhizen Pharmaceuticals ^Company

Rhizen Pharmaceuticals is a biopharmaceutical company that is currently in the clinical stage of drug development. They focus on creating small molecule drugs that target signal transduction networks and ion channels to treat cancer, inflammation, autoimmune diseases, and metabolic disorders. The company aims to generate first-best-early in class compounds that provide new therapeutic options for unmet medical needs. Rhizen operates as a virtual company and outsources to globally reputed laboratories while progressing from pre-clinical to clinical development.